Novo Nordisk launches Wegovy in India, targets obesity treatment market, offers semaglutide-based weekly injection
Tuesday, 24 June 2025 () Novo Nordisk has launched Wegovy in India, an anti-obesity drug aimed at managing weight and reducing cardiovascular risks. Priced between Rs 17,345 and Rs 26,050 per month, the injectable drug targets India's large obese population. The company aims to create awareness and collaborate with stakeholders to combat obesity, citing its significant impact on India's GDP.
U.S. Senator Lindsey Graham tore into Russian President Vladimir Putin for backing Iran after Israel's massive retaliatory strikes, calling Moscow's legal advice on warfare "rich even for the..
Russia has confirmed that it carried out a massive high-precision strike on military-industrial targets in Ukraine’s capital, Kiev. The Defense Ministry said it hit missile, aircraft, tank, and..
Mumbai: In an exclusive interview with Actress Hina Khan, where she shared her positive experience with India's healthcare system, highlighting its advancements under the current government,..